Clinical Trial Update: Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer [NA]

View source ↗

Summary

Clinical trial evaluating genetic sequencing-informed targeted therapy for stage IIIB-IV non-small cell lung cancer has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pericardial Effusion
• Malignant Pleural Effusion
• Non-small Cell Lung Cancer

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Malignant Pericardial Effusion, Malignant Pleural Effusion | NA | Status: TERMINATED | Results posted: 2018-01-16